The content is available as a PDF (528.0 KB).
. 1985 Apr;151(4):731–736. doi: 10.1093/infdis/151.4.731
Intranasal Interferon-α2 Prophylaxis of Natural Respiratory Virus Infection
Robert M Douglas
1,2, Janice K Albrecht
1,2, Helen B Miles
1,2, Brian W Moore
1,2, Ron Read
1,2, David A Worswick
1,2, Alistair J Woodward
1,2
Robert M Douglas
1
Department of Community Medicine, University of Adelaide and the Institute of Medical and Veterinary Science, Adelaide, Australia
2
Research Division, Schering Corporation, Kenilworth, New Jersey
Find articles by Robert M Douglas
Janice K Albrecht
1
Department of Community Medicine, University of Adelaide and the Institute of Medical and Veterinary Science, Adelaide, Australia
2
Research Division, Schering Corporation, Kenilworth, New Jersey
Find articles by Janice K Albrecht
Helen B Miles
1
Department of Community Medicine, University of Adelaide and the Institute of Medical and Veterinary Science, Adelaide, Australia
2
Research Division, Schering Corporation, Kenilworth, New Jersey
Find articles by Helen B Miles
Brian W Moore
1
Department of Community Medicine, University of Adelaide and the Institute of Medical and Veterinary Science, Adelaide, Australia
2
Research Division, Schering Corporation, Kenilworth, New Jersey
Find articles by Brian W Moore
Ron Read
1
Department of Community Medicine, University of Adelaide and the Institute of Medical and Veterinary Science, Adelaide, Australia
2
Research Division, Schering Corporation, Kenilworth, New Jersey
Find articles by Ron Read
David A Worswick
1
Department of Community Medicine, University of Adelaide and the Institute of Medical and Veterinary Science, Adelaide, Australia
2
Research Division, Schering Corporation, Kenilworth, New Jersey
Find articles by David A Worswick
Alistair J Woodward
1
Department of Community Medicine, University of Adelaide and the Institute of Medical and Veterinary Science, Adelaide, Australia
2
Research Division, Schering Corporation, Kenilworth, New Jersey
Find articles by Alistair J Woodward
1
Department of Community Medicine, University of Adelaide and the Institute of Medical and Veterinary Science, Adelaide, Australia
2
Research Division, Schering Corporation, Kenilworth, New Jersey
We thank the administrator and staff of the Royal Adelaide Hospital; the Director and staff of the Institute of Medical and Veterinary Science; Dr. D. A. J. Tyrrell, M.R.C. Common Cold Research Unit, Salisbury, U.K. for provision of reagents, coronavirus, ELISA test, and technical advice; Drs. M. Rallings and R. Varin of Schering Corporation; Research Nurses M. Logan, A. Hogben, A. Kerr, C. Sandow, L. Davies, S. Lewis, J. Davis, and S. Freeman for assistance in the conduct of the study; Professor B. Marmion of the Institute of Medical and Veterinary Science for technical advice; and Mrs. E. Brown for secretarial assistance.
This work was supported by a grant from the Schering Corporation.
Please address requests for reprints to Dr. R. M. Douglas, Department of Community Medicine, University of Adelaide, Royal Adelaide Hospital, Adelaide, South Australia 5001, Australia.
Received 1984 Jun 6; Revised 1984 Oct 16; Issue date 1985 Apr.
© 1985 by The University of Chicago
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7109831 PMID: 2982972